DNA increases the potency of vaccination against infectious diseases

Current Opinion in Chemical Biology

Volumn 1, Issue 2, 1997, Pages 183-189

  Wahren, Britta ^a   Brytting, Maria ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; HERPES; HUMAN HERPESVIRUS 2;

DNA VACCINE;

BIOTECHNOLOGY; HUMAN; INFECTION CONTROL; REVIEW;

BIOTECHNOLOGY; COMMUNICABLE DISEASE CONTROL; HUMANS; VACCINES, DNA;

EID: 0031197121     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(97)80008-7     Document Type: Article

References (56)

1. Barry MA, Lai WC, Johnston SA: Protection against mycoplasma infection using expression-library immunization. Nature 1995, 377:632-635.
2. McMillan M: The design of minigenes as DNA vaccines for HIV therapy in Genetic vaccines and immunotherapeutic strategies. In Genetic Vaccines and Immunotherapeutic Strategies. Southborough, MA: IBC Library series; 1997: in press.
3. Wahren B, Brytting M, Engström G, Hinkula J, Levi M, Ljungdahl Ståhle E, Ohlsson S, Rudén U, Schwartz S: Immune responses to the HIV rev regulatory gene. Antibiot Chemother 1996, 48:105-112.
4. Hinkula J, Svanholm C, Schwartz S, Lundholm P, Brytting M, Engström G, Benthin R, Glaser H, Kohleisen B, Erfle V et al.: Recognition of prominent viral epitopes induced by immunization with human immunodeficiency virus type 1 regulatory genes. J Virol 1997, 71:5528-5539. Regulatory gene products establish good immune responses by DNA vaccination on mucosal surfaces.
5. Miller RH, Sarver N: HIV accessory proteins as therapeutic targets. Nat Med 1997, 3:389.
6. Asakura Y, Hamajima K, Fukushima J, Mohri H, Okubo T, Okuda K: Induction of HIV-1 Nef-specific cytotoxic T lymphocytes by Net-expressing DNA vaccine. Am J Hematol 1996, 53:116-117.
7. Mancini M, Hadchouel M, Davis HL, Whalen RG, Tiollais P, Michel M-L: DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state. Proc Natl Acad Sci USA 1996, 93: 12496-12501. The authors have shown that it is possible to break tolerance to the hepatitis virus antigens by DNA immunization. New immunity developed without liver cell damage.
8. Lai WC, Pakes SP, Ren K, Lu Y-S, Bennett M: Therapeutic effect of DNA immunization of genetically susceptible mice infected with virulent Mycoplasma pulmonis. J Immunol 1997, 158:2513-2516. The therapeutic role of DNA immunization is shown for the first time.
9. Krasemann S, Groschup M, Hunsmann G, Bodemer W: Generation of monoclonal antibodies against prion proteins by DNA- and virus-mediated immunization of PRP 0/0-mice. In Vaccines 97: Molecular Approaches to the Control of Infectious Diseases. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1997: 265-277.
10. Ertl HCJ, Xiang Z: Novel vaccine approaches. J Immunol 1997, 156:3579-3582.
11. Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Feigner PL, Dwarki VJ, Gromkovski SH, Deck RR, DeWitt CM, Friedman A et al.: Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993, 259:1745-1749.
12. Fu TM, Friedman A, Ulmer JB, Liu MA, Donnelly JJ: Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization. J Virol 1997, in press.
13. Wahren B, Hinkula J, Ljungdahl Ståhle E, Borrebaeck C, Schwartz S, Wigzell H: Nucleic acid vaccination with HIV regulatory genes. Ann N Y Acad Sci 1995, 772:278-281.
14. Doe B, Selby M, Barnett S, Baenziger J, Walker CM: Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc Natl Acad Sci USA 1996, 93:8578-8583.
15. Corr M, Lee DJ, Carson DA, Tighe H: Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J Exp Med 1996, 184:1555-1560.
16. Ulmer JB, Deck RR, DeWitt CM, Donnelly JJ, Liu MA: Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells. Immunology 1996, 89:59-67. Antigen-presenting cells are shown to be of hematopoietic origin, even though immunization was performed intramuscularly.
17. Robinson HL, Hunt LA, Webster RG: Protection against a lethal influenza virus challenge by immunization with a hemagglutinin-expressing plasmid DNA. Vaccine 1993, 11:957-960.
18. Deck RR, DeWitt CM, Donnelly JJ, Liu MA, Ulmer JB: Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine. Vaccine 1997, 15:71-78. The authors demonstrate that DNA-induced antibodies react broadly to influenza virus.
19. Waisman A, Ruiz PJ, Hirschberg DL, Gelman A, Oksenberg JR, Brocke S, Mor F, Cohen IR, Steinman L: Suppressive vaccination with DNA encoding a variable region genen of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nat Med 1996, 2:899-905. One of the first studies to show that the alteration of Th1 responses to Th2 also confers clinical effects in allergic or autoimmune disease.
20. Bourne N, Stanberry LR, Bernstein DI, Lew D: DNA immunization against experimental genital herpes simplex virus infection. J Infect Dis 1996, 173:800-807.
21. Kuklin N, Daheshia M, Karem K, Manickan E, Rouse B: Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J Virol 1997, 71:3138-3145.
22. Donnelly JJ, Martinez D, Jansen KU, Ellis RW, Montgomery DL, Liu MA: Protection against papilloma virus with a polynucleotide vaccine. J Infect Dis 1996, 173:314-320.
23. Boyer JD, Ugen KE, Wang B, Agadjanyan M, Gilbert L, Bagarazzi ML, Chattergoon M, Frost P, Javadian A, Williams WV: Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nat Med 1997, 3:525-532. Chimpanzees were protected from the induction of HIV-infection in that only very short term virus was recovered by PCR. The possibility of developing protection to a high challenge dose was demonstrated.
24. Boyer JD, Wang B, Ugen KD, Agadjanyan M, Javadian A, Frost P, Dang K, Carrano RA, Ciccarelli R, Coney L et al.: In vivo protective anti-HIV immune responses in non-human primates through DNA immunization. J Med Primatol 1996, 25:242-250.
25. Ugen KE, Boyer J, Wang B, Nyland S, Carmack B, MacGregor RR, Gluckman S, Bagarazzi M, Coney L, Carrano R et al.:Facilitated nucleic acid vaccinations of humans with an HIV-1 expressing DNA plasmid boosts immune responses against viral proteins. In Vaccines 97: Molecular Approaches to the Control of Infectious Diseases. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1997: 145-150.
26. Wahren B, Hinkula J, Lundholm P, Okuda K, Borrebaeck C, Schwartz S: Nucleic acid vaccination with HIV regulatory genes. Genes that induce immunity [abstract]. In Proceedings of the Nobel Symposium: 1996; Karolinska Institute. Edited by Wahren B, Wigzell H. Stockholm: Karolinska Institute; 1996:30.
27. •]
28. ••].
29. ••].
30. ••].
31. ••].
32. ••].
33. Fuller JT, Macklin M, Drape B, Swain W, McCabe D, Swain WF1 Haynes JR1 Widera G: Gene-gun mediated DNA immunization with HBV antigens: efficacy in small and large animals. In Vaccines 97: Molecular Approaches to the Control of Infectious Diseases. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1997: 157-162.
34. Prince A, Whalen R, Taylor P, Brotman B: Nucleic acid based immunization of newborn chimpanzees. In Vaccines 97: Molecular Approaches to the Control of Infectious Diseases. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1997: 141-144.
35. Davis HL, McCluskie MJ, Gerin JL, Purcell RH: DNA vaccine for hepatitis B: immunogenicity in chimpanzees and comparison with other vaccines. Proc Natl Acad Sci USA 1996, 93:7213-7218.
36. Huygen K, Content J, Denis O, Montgomery D, Yawman A, Deck R, DeWitt C, Orme J, Baldwin S, D'Souza C et al.: Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med 1996, 2:893-898.
37. Tascon R, Colston M, Ragno S, Stavropoulos E, Gregary D, Lowrie D: Vaccination against tuberculosis by DNA injection. War Med 1996, 2:888-892.
38. Raz E, Tighe H, Sato Y, Corr M, Dudler JA, Roman M, Swain SL, Spiegelberg HL, Carson DA: Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc Natl Acad Sci USA 1996,93:5141-5145.
39. Doolan DL, Sedegah M, Hedstrom RC, Hobart P, Charoenvit Y, Hoffman SL: Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8 cell-, interferon gamma- and nitric oxide-dependent immunity. J Exp Med 1996, 183:1739-1746.
40. Gould-Fogerite S, Mannino RJ: Mucosal and systemic immunization using cochleate and liposome vaccines. J Liposome Res 1996, 6:357-379. The authors show the novel use of a compound that protects DNA when delivered to animal cells.
41. Wheeler CJ, Felgner PL, Tsai YJ, Marshall J, Sukhu L, Don SG, Hartikka J, Nietupski J, Manthorpe M, Nichols M et al.: A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung. Proc Natl Acad Sci USA 1996, 93:11454-11459.
42. Haynes JR, Fuller DH, McCabe D, Swain WF, Widera G: Induction and characterization of humoral and cellular immune responses elicited via gene gun-mediated nucleic acid immunization. Adv Drug Delivery Rev 1996, 21:3-18.
43. Condon C, Watkins SC1 Celluzzi C, Thompson K, Falo LD: DNA-based immunization by in vivo transfection of dendritic cells. Nat Med 1996, 2:1122-1128.
44. Donnelly JJ, Ulmer JB, Shiver JW, Liu MA: DNA vaccines. Ann Rev Immunol 1997, in press.
45. McDonnel WM, Askari FK: DNA vaccines. New Engl J Med 1996, 334:42-45.
46. Wahren B: Gene vaccines. Immunotechnol 1996, 2:77-83.
47. Davis HL, Mancini M-L, Michel RG, Whalen RG: DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost Vaccine 1996, 14:910-915.
48. Hartikka J, Sawdey M, Cornefert-Jensen F, Margalith M, Barnhart K, Nolasco M, Vahlsing HL, Meek J1 Marquet M, Hobart P: An improved plasmid DNA expression vector for direct injection into skeletal muscle. Hum Gene Ther 1996, 7:1205-1217. The authors have carried out essential work examining the role of DNA sequences in plasmid DNA vaccines.
49. Huang MTF, Gorman CM: Intervening sequences increase efficiency of RNA 3′ processing and accumulation of cytoplasmic RNA. Nucleic Acids Res 1990, 18:937-946.
50. Sato Y, Roman M, Tighe H, Lee D, Corr M, Nguyen M-D, Silverman GJ, Lotz M, Carson DA, Raz E: Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 1996, 273:299-302. The authors demonstrate that the backbone of the DNA plasmid can affect the induction of immune reactions.
51. Halpern MD, Kurlander RJ, Pisetsky DS: Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha. Cell Immunol 1996, 167:72-78.
52. Raz E, Watanabe A, Baird SM, Eisenberg RA, Parr TB, Lotz M, Kipps TJ, Carson DA: Systemic immunological effects of cytokine genes injected into the skeletal muscle. Proc Natl Acad Sci USA 1993, 90:4523-4527.
53. Xiang Z, Ertl HCJ: Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 1995, 2:129-135.
54. Kim JJ, Ayyavoo V, Bagarazzi ML, Chattergoon MA, Dang K, Boyer JD, Weiner DB: In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J Immunol 1997, 158:816-826.
55. Rakhmilevich AL, Turner JT, Ford MJ, McCabe D, Sun WH, Sondel PM, Grota K, Yang N-S: Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors. Proc Natl Acad Sci USA 1996, 93:6291-6296.
56. Haseltine W: Discovering genes for new medicines. Sci Am March 1997:78-83. The author describes strategies being used to identify new disease genes by examining human genome sequences.